Silk Road Medical competitors

John Onopchenko is a Board Member at Synecor, Board Member at Endologix Inc, and Chief Executive Officer at Endologix Inc. He has worked as Chief Operating Officer at VOLCANO CO., LTD.; Chief Operating Officer at Endologix Inc; and Exec VP:Strategy at VOLCANO CO., LTD.. John works or has worked as VP:Venture Investments at Johnson & Johnson Innovation - Jjdc Inc, Managing Director/Gen Partner at Synergy Life Sciences Partners, and MEMBER at FINRA. He studied at University of Chicago Booth School of Business and Ursinus College.

Albert D. Bolles, Ph.D. joined the board of directors in May 2018. He is the CEO of Landec Corporation, a company that designs, develops, manufactures and sells health and wellness products for food and biomaterials markets. Before joining Landec, Dr. Bolles served as the executive vice president, chief technology and operations officer of ConAgra Foods, where he directed the development and execution of multiple product innovations. Prior to ConAgra, he was the vice president of worldwide research and development for PepsiCo Beverages and Foods and the research and development director for Gerber Foods. Dr. Bolles is a graduate of Michigan State University, where he earned Ph.D. and M.S. degrees in food science and a bachelors’ degree in microbiology. He holds several patents and has won numerous awards for his contributions to food science, the industry and academics.

Matt Ronet was appointed to Lumileds CEO October 20202. Roney most recently served as President of Lumileds’ Automotive Business Unit. After more than 20 years in leadership roles at automotive and industrial businesses, Mr. Roney brings a broad range of business experience to Lumileds. Prior to joining Lumileds, Roney served as Chief Operating Officer for Stanley Infrastructure, a division of Stanley Black & Decker. Previously, Roney was the President of Paladin Attachments, which was acquired by Stanley Infrastructure. He also spent eight years at TRW Automotive, now known as ZF TRW, in roles of rising responsibility, including Vice President and General Manager of its $2.5 billion Global Steering Business. Roney has a BS in Electrical Engineering from Cornell University, an MSE in Mechanical Engineering from Purdue, and an MBA from Harvard Business School.

Bruce Shook is a medical device executive with more than 30 years of industry experience, including multiple early stage ventures focused on opportunities in cardiac surgery, cardiology, neurosurgery, psychiatry and vascular disease. He serves as Director, President and CEO for both Intact Vascular and Vesper Medical. Intact Vascular is a privately held medical technology company that develops and commercializes vascular scaffolding technology for the treatment of peripheral arterial disease. The company is currently marketing the Tack Endovascular System® in the U.S. and Europe. Vesper Medical was spun out of Intact Vascular in late 2016 and is developing a novel family of venous stents designed to treat deep venous disease. Prior to Intact Vascular and Vesper Medical, Mr. Shook was co-founder, Director, President and CEO of Neuronetics, Inc., [NASDAQ: STIM] a publicly traded device company that markets a non-invasive brain stimulation technology for the treatment of depression. Previously, Mr. Shook was co-founder, Director, President and CEO at Neuron Therapeutics, a venture-backed company developing a drug/device product for the treatment of CNS disorders, and President of Abiomed [NASDAQ: ABMD], where he obtained PMA approval for the first FDA-approved ventricular assist device. Mr. Shook also developed cardiac pacing and anti-arrhythmia products at Cordis Corporation. Mr. Shook holds advanced degrees in Biomedical Engineering and Business Administration from Columbia University and the MIT Sloan School of Management, respectively. He earned a B.S. degree in Chemical Engineering from Penn State University. Mr. Shook currently serves on the Board of Directors at Neuronetics, Venarum Medical, the Penn State Research Foundation (Vice Chairman) and Life Sciences Pennsylvania (Medical Technology Committee Chairman). He previously served on the Board of Directors at Surgiquest, Respicardia and CoTherix.